INVESTING IN PENSACOLA/ESCAMBIA COUNTY Escambia County and Pensacola are well-positioned for an increase in diversified economic growth led by technology, manufacturing, defense and logistics business sectors. In particular, the community has seen substantial growth in early-stage technology companies that are attracted to Pensacola in part because the area offers an exceptional quality of life for … Read more
FloridaWest News
Longtime Pensacola engineering firm, Baskerville Donovan, partnered with the city of Pensacola to craft the stunning Maritime Park Breakwater. In bustling downtown areas, marinas crave protection from strong winds and waves, and that’s exactly what this breakwater brings to Pensacola Bay. “During storms, this structure steps up to shield against powerful wave action,” said Freddy … Read more
Find out why Pensacola is where quality of life meets quality of business. From The Points Guy. “From the stops along the Mississippi Blues Trail to lunch counter sit-ins and tours around the Chitlin Circuit, there is more to Pensacola and its history than breathtaking blue waters. Amid the Jim Crow era, with growing tensions … Read more
BlueWind, an Escambia County manufacturer of high-performance composite materials — chiefly nacelles or wind turbine housings— was honored by GE Vernova at the 2023 General Electric Onshore Wind Supplier Conference and Awards held at Pensacola Beach, Florida. BlueWind was named “Supplier Spirit of Alliance,” an award given to only 22 companies among all of GE’s … Read more
The National Security Agency and U.S. Department of Homeland Security recently designated Pensacola State College as a National Center of Academic Excellence in Cyber Defense (CAE-CD) through 2028. The CAE-CD designation is awarded to regionally accredited academic institutions offering cybersecurity degrees and/or certificates at the associate, baccalaureate and graduate levels. “To receive the designation, institutions … Read more
Circulogene, a specialized oncology diagnostics company, uses patients’ blood to test for molecular biomarkers which may be used to guidetargeted and immunotherapy treatment options in cancer patients at the time of diagnosis and recurrence. In 2023, the company flourished, completing a merger and preparing for big growth in 2024. President & CEO Mike Mullen said 2023 was a year of … Read more